Drug-induced thrombotic thrombocytopenic purpura : A systematic review and review of European and North American pharmacovigilance data
© 2022 British Society for Haematology and John Wiley & Sons Ltd..
Many medications have been reported to be associated with thrombotic thrombocytopenic purpura (TTP) through pharmacovigilance data and published case reports. Whilst there are existing data available regarding drug-induced thrombotic microangiopathy, there is no available synthesis of evidence to assess drug-induced TTP (DI-TTP). Despite this lack of evidence, patients with TTP are often advised against using many medications due to the theoretical risk of DI-TTP. This systematic review evaluated the evidence for an association of medications reported as potential triggers for TTP. Of 5098 records available 261 articles were assessed further for eligibility. Fifty-seven reports, totalling 90 patients, were included in the final analysis. There were no cases where the level of association was rated as definite or probable, demonstrating a lack of evidence of any drug causing DI-TTP. This paucity of evidence was also demonstrated in the pharmacovigilance data, where 613 drugs were reported as potential causes of TTP without assessment of the strength of association. This systematic review demonstrates the need for standardised reporting of potential drugs causing TTP. Many reports omit basic information and, therefore, hinder the chance of finding a causative link if one exists.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:201 |
|---|---|
| Enthalten in: |
British journal of haematology - 201(2023), 4 vom: 22. Mai, Seite 766-773 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schofield, Jeremy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case report |
|---|
| Anmerkungen: |
Date Completed 04.05.2023 Date Revised 11.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjh.18577 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349901686 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349901686 | ||
| 003 | DE-627 | ||
| 005 | 20231226043730.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjh.18577 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1166.xml |
| 035 | |a (DE-627)NLM349901686 | ||
| 035 | |a (NLM)36477772 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schofield, Jeremy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug-induced thrombotic thrombocytopenic purpura |b A systematic review and review of European and North American pharmacovigilance data |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.05.2023 | ||
| 500 | |a Date Revised 11.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 British Society for Haematology and John Wiley & Sons Ltd. | ||
| 520 | |a Many medications have been reported to be associated with thrombotic thrombocytopenic purpura (TTP) through pharmacovigilance data and published case reports. Whilst there are existing data available regarding drug-induced thrombotic microangiopathy, there is no available synthesis of evidence to assess drug-induced TTP (DI-TTP). Despite this lack of evidence, patients with TTP are often advised against using many medications due to the theoretical risk of DI-TTP. This systematic review evaluated the evidence for an association of medications reported as potential triggers for TTP. Of 5098 records available 261 articles were assessed further for eligibility. Fifty-seven reports, totalling 90 patients, were included in the final analysis. There were no cases where the level of association was rated as definite or probable, demonstrating a lack of evidence of any drug causing DI-TTP. This paucity of evidence was also demonstrated in the pharmacovigilance data, where 613 drugs were reported as potential causes of TTP without assessment of the strength of association. This systematic review demonstrates the need for standardised reporting of potential drugs causing TTP. Many reports omit basic information and, therefore, hinder the chance of finding a causative link if one exists | ||
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a case report | |
| 650 | 4 | |a pharmacovigilance | |
| 650 | 4 | |a systematic review | |
| 650 | 4 | |a thrombocytopenic purpura | |
| 650 | 4 | |a thrombotic | |
| 700 | 1 | |a Hosseinzadeh, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Burton, Kieran |e verfasserin |4 aut | |
| 700 | 1 | |a Pavord, Sue |e verfasserin |4 aut | |
| 700 | 1 | |a Dutt, Tina |e verfasserin |4 aut | |
| 700 | 1 | |a Doree, Carolyn |e verfasserin |4 aut | |
| 700 | 1 | |a Lim, Wen Yuen |e verfasserin |4 aut | |
| 700 | 1 | |a Desborough, Michael J R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d 1955 |g 201(2023), 4 vom: 22. Mai, Seite 766-773 |w (DE-627)NLM000000396 |x 1365-2141 |7 nnns |
| 773 | 1 | 8 | |g volume:201 |g year:2023 |g number:4 |g day:22 |g month:05 |g pages:766-773 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjh.18577 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 201 |j 2023 |e 4 |b 22 |c 05 |h 766-773 | ||